HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
139476.0,203250,2114-11-03 10:05:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   Mitral Valve
   thrombus
   24 Hour Events:
   Patient had increased O2 requirement overnight, worsening rales on
   exam. Patient had started BiPap, then was Diuresed.  O2 requirement
   improved.  R IJ placed as PIVs difficult to place.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2114-11-3**] 03:31 AM
   Furosemide (Lasix) - [**2114-11-3**] 05:04 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-3**] 09:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 37.6
C (99.6
   HR: 110 (67 - 112) bpm
   BP: 105/62(73) {85/38(59) - 119/72(79)} mmHg
   RR: 24 (21 - 33) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    141 mL
                                                                    338 mL
   PO:
                                                                    120 mL
             TF:
   IVF:
                                                                     21 mL
                                                                    338 mL
   Blood products:
   Total out:
                                                                    510 mL
                                                                  1,080 mL
   Urine:
                                                                    510 mL
                                                                  1,080 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -369 mL
                                                                   -742 mL
   Respiratory support
   O2 Delivery Device: Other
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 1,046 (1,046 - 1,046) mL
   PS : 10 cmH2O
   RR (Spontaneous): 32
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ///22/
   Ve: 6.6 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   355 K/uL
   9.0 g/dL
   155 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.0 mEq/L
   23 mg/dL
   113 mEq/L
   144 mEq/L
   25.9 %
   25.0 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.8/67.9/1.5, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:1.3 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN 66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**])
   with AV and MV valves transferred from OSH with MV thrombosis and GI
   bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   .
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2114-11-3**] 04:37 AM
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   Mitral Valve
   thrombus
   24 Hour Events:
   Patient had increased O2 requirement overnight, worsening rales on
   exam. Patient had started BiPap, then was Diuresed.  O2 requirement
   improved.  R IJ placed as PIVs difficult to place.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2114-11-3**] 03:31 AM
   Furosemide (Lasix) - [**2114-11-3**] 05:04 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-3**] 09:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 37.6
C (99.6
   HR: 110 (67 - 112) bpm
   BP: 105/62(73) {85/38(59) - 119/72(79)} mmHg
   RR: 24 (21 - 33) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    141 mL
                                                                    338 mL
   PO:
                                                                    120 mL
             TF:
   IVF:
                                                                     21 mL
                                                                    338 mL
   Blood products:
   Total out:
                                                                    510 mL
                                                                  1,080 mL
   Urine:
                                                                    510 mL
                                                                  1,080 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -369 mL
                                                                   -742 mL
   Respiratory support
   O2 Delivery Device: Other
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 1,046 (1,046 - 1,046) mL
   PS : 10 cmH2O
   RR (Spontaneous): 32
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ///22/
   Ve: 6.6 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   355 K/uL
   9.0 g/dL
   155 mg/dL
   1.0 mg/dL
   22 mEq/L
   4.0 mEq/L
   23 mg/dL
   113 mEq/L
   144 mEq/L
   25.9 %
   25.0 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.8/67.9/1.5, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:1.3 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN 66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**])
   with AV and MV valves transferred from OSH with MV thrombosis and GI
   bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   .
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2114-11-3**] 04:37 AM
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications are potential concerns:

1. Thrombus progression: The patient has a prosthetic mitral valve thrombus, and the management plan includes continuing heparin and considering surgery in the future. There is a risk of further thrombus progression, which could lead to cardiac complications.
2. Atrial fibrillation: The patient has poorly rate-controlled atrial fibrillation, which can increase the risk of thrombus formation and embolic events.
3. Congestive heart failure: The patient has acute congestive heart failure secondary to mitral valve thrombus and atrial fibrillation, which can lead to further cardiac complications.
4. GI bleed: The patient has had a recent GI bleed, and the source is unclear. There is a risk of further bleeding, which could lead to hypovolemic shock and other complications.
5. Pneumonia: The patient has possible RLL pneumonia, which could lead to respiratory failure and other complications.
6. Infection: The patient has a high white blood cell count, which could indicate an infection. The differential diagnosis includes infected thrombus, and further testing is needed to determine the cause of the leukocytosis.
7. Hypothyroidism: The patient has hypothyroidism, which could be exacerbated by the patient's current condition and medications.
8. Neurological deficits: The patient has neurological deficits on exam, which could be related to the patient's recent hemorrhagic stroke. There is a risk of further embolic events.
9. Hypertension: The patient has hypertension, which could be exacerbated by the patient's current condition and medications.

The patient's current medications include heparin, lasix, metoprolol, and protonix, among others. The patient's laboratory results show elevated white blood cell count, troponin-T, and lactate levels, which could indicate cardiac or respiratory complications.

The patient's plan of care includes starting low-dose metoprolol for heart rate control, continuing heparin for thrombus progression, and considering surgery in the future. The patient will also require close monitoring for signs of cardiac, respiratory, or neurological complications."
139476.0,203250,2114-11-04 05:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Tele: HR improved with metoprolol.  Desats at 11 PM.  Prior to CPAP.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     144
                               [image002.gif]
                                     111
                               [image002.gif]
                                     22
   [image004.gif]
   133
                                                                   AGap=12
   [image005.gif]
   3.5
                               [image002.gif]
                                     25
                               [image002.gif]
                                     1.2
   [image007.gif]
   Mg: 2.1
   Source: Line-central
   93
                                                                      21.3
                                                            [image007.gif]
                                     8.9
   [image004.gif]
   275
                 [image008.gif]
   [image004.gif]
                                    26.7
   [image007.gif]
   Source: [**Name (NI) 6416**]
   PT: 15.8
   PTT: 65.8
   INR: 1.4
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Post transfusion
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   .
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   .
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Tele: HR improved with metoprolol.  Desats at 11 PM.  Prior to CPAP.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
                                     144
                               [image002.gif]
                                     111
                               [image002.gif]
                                     22
   [image004.gif]
   133
                                                                   AGap=12
   [image005.gif]
   3.5
                               [image002.gif]
                                     25
                               [image002.gif]
                                     1.2
   [image007.gif]
   Mg: 2.1
   Source: Line-central
   93
                                                                      21.3
                                                            [image007.gif]
                                     8.9
   [image004.gif]
   275
                 [image008.gif]
   [image004.gif]
                                    26.7
   [image007.gif]
   Source: [**Name (NI) 6416**]
   PT: 15.8
   PTT: 65.8
   INR: 1.4
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Post transfusion
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   .
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   .
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 66-year-old female who was admitted to the ICU with a history of CVA, hemorrhagic evolution, and mechanical mitral valve thrombosis. She has been experiencing acute congestive heart failure secondary to mitral valve thrombus and atrial fibrillation. She has also had a GI bleed, which is unclear in origin, and is at risk for further embolic events due to the thrombus.

The patient's current condition is as follows:

* Respiratory support: Non-invasive ventilation with CPAP/PSV
* Cardiovascular: Atrial fibrillation, severe aortic stenosis, and mitral stenosis due to prosthetic valve thrombus
* Gastrointestinal: Unclear source of bleeding, likely lower GI
* Neurological: Hemorrhagic stroke with ongoing neurological deficits
* Hematological: Thrombocytopenia, anemia
* Laboratory results:
	+ WBC: 25.0
	+ Hct: 25.9
	+ Platelets: 321
	+ Troponin-T: 0.05
	+ Lactic acid: 2.7 mmol/L
	+ Albumin: 2.9 g/dL
	+ LDH: 462 IU/L
	+ Ca++: 8.1 mg/dL
	+ Mg++: 2.1 mg/dL
	+ PO4: 1.8 mg/dL

Potential medical complications:

1. Worsening heart failure: The patient's mitral valve thrombus and atrial fibrillation are causing significant cardiac compromise, which could lead to further decline in cardiac function.
2. Thrombotic events: The patient's history of CVA and ongoing thrombosis risk due to the prosthetic valve thrombus make her susceptible to further thrombotic events.
3. Gastrointestinal bleeding: The patient's unclear source of bleeding and ongoing anemia increase the risk of further bleeding episodes.
4. Respiratory failure: The patient's respiratory support is currently adequate, but she may require more aggressive respiratory therapy if her condition worsens.
5. Infection: The patient's elevated WBC and lactate levels suggest the possibility of infection, which could be further complicated by her immunosuppressed state.
6. Kidney injury: The patient's elevated LDH and creatinine levels suggest the possibility of kidney injury, which could be exacerbated by her cardiac and respiratory compromise.
7. Electrolyte imbalance: The patient's hypokalemia and hypomagnesemia may require close monitoring and treatment to prevent further complications.
8. Nutritional deficiencies: The patient's anemia and hypoalbuminemia suggest the possibility of nutritional deficiencies, which could be addressed through enteral nutrition support.
9. Psychosocial issues: The patient's ongoing neurological deficits and limited mobility may impact her quality of life and require psychosocial support.

Plan:

1. Continue respiratory support with non-invasive ventilation and monitor for signs of worsening respiratory failure.
2. Manage the patient's cardiac condition with ongoing therapy for atrial fibrillation and mitral stenosis.
3. Investigate the source of the patient's gastrointestinal bleeding and treat accordingly.
4. Monitor the patient's neurological status and provide ongoing rehabilitation therapy to address her deficits.
5. Manage the patient's hematological abnormalities with transfusions and platelet support as needed.
6. Monitor the patient's electrolyte levels and treat any imbalances promptly.
7. Consider enteral nutrition support to address the patient's nutritional deficiencies.
8. Provide psychosocial support to address the patient's ongoing neurological deficits and limited mobility."
139476.0,203250,2114-11-04 05:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2114-11-3**] 12:15 PM
 NON-INVASIVE VENTILATION - START [**2114-11-3**] 06:27 PM
 EKG - At [**2114-11-3**] 08:00 PM
 FEVER - 101.6
F - [**2114-11-3**] 10:00 PM
   TEE showed thrombus increasing in size.  Family meeting: plan not to
   escalate care.  Would make CMO if worsening.  GI recommended CT scan
   when more stable and following lactate.  Tachycardia responded well to
   5 mg metoprolol bolus in AM and PM.  Hypoxic -> ABG, CXR, CPAP o/n.
   Fevers through vanc/[**Last Name (un) 430**].
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2114-11-4**] 12:00 AM
   Metronidazole - [**2114-11-4**] 01:59 AM
   Meropenem - [**2114-11-4**] 03:00 AM
   Infusions:
   Heparin Sodium - 800 units/hour
   Other ICU medications:
   Furosemide (Lasix) - [**2114-11-3**] 10:00 AM
   Fentanyl - [**2114-11-3**] 12:15 PM
   Midazolam (Versed) - [**2114-11-3**] 12:16 PM
   Metoprolol - [**2114-11-3**] 08:25 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-4**] 05:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.7
C (101.6
   Tcurrent: 36.9
C (98.5
   HR: 86 (84 - 112) bpm
   BP: 97/47(60) {77/36(47) - 118/72(82)} mmHg
   RR: 24 (16 - 33) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: -4 (-4 - 326)mmHg
   Total In:
                                                                  1,439 mL
                                                                    475 mL
   PO:
   TF:
   IVF:
                                                                  1,064 mL
                                                                    475 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                  2,765 mL
                                                                    560 mL
   Urine:
                                                                  2,765 mL
                                                                    560 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,326 mL
                                                                    -85 mL
   Respiratory support
   O2 Delivery Device: Bipap mask
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 849 (578 - 1,363) mL
   PS : 10 cmH2O
   RR (Spontaneous): 30
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.44/34/69//0
   Ve: 4.4 L/min
   PaO2 / FiO2: 138
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  CN II-XII intact, with following exceptions. [**2-21**] Plantar
   flexion of L and R LE.  [**3-24**] handgrip on R, [**1-23**] on L.  Absent L sided
   startle reflex, L lid lag and facial droop.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
   WBC
   20.8
   25.0
   Hct
   29.3
   25.9
   32
   Plt
   321
   355
   Cr
   1.0
   1.0
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   Other labs: PT / PTT / INR:16.1/58.9/1.4, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.1 mg/dL, Mg++:2.1 mg/dL, PO4:1.8 mg/dL
   The left atrium is dilated. Mild spontaneous echo contrast is seen in
   the body of the left atrium. Moderate to severe spontaneous echo
   contrast is present in the left atrial appendage. The left atrial
   appendage emptying velocity is depressed (<0.2m/s). A probable thrombus
   is seen in the tip of the left atrial appendage. No atrial septal
   defect is seen by 2D or color Doppler. There are simple atheroma in the
   ascending aorta. There are simple atheroma in the aortic arch. There
   are simple atheroma in the descending thoracic aorta up to 35cm from
   the incisor. The aortic valve leaflets (3) are moderately thickened.
   There is severe aortic valve stenosis (area 0.6cm2 by planimetry).
   Trace aortic regurgitation is seen. [Due to acoustic shadowing, the
   severity of aortic regurgitation may be significantly UNDERestimated.]
   A mechanical mitral valve prosthesis is present. There is extensive
   thrombus around the ring of the prosthesis that measures at least 3.4cm
   by 1.1cm by dimension. There is a highly mobile component of the
   thrombus that measure 1.9cm x 0.5cm that prolapses through the mitral
   valve orifice. The anterior/septal mitral valve leaflet is completely
   immobile. The posterior/lateral leaflet moves well. The gradients
   across the mitral valve is suggestive of severe valvular mitral
   stenosis. A tricuspid valve annuloplasty ring is present with trace
   tricuspid regurgitation. There is no pericardial effusion.
   Impression: Extensive thrombus around the mechanical mitral prosthesis
   causing severe mitral stenosis. Severe aortic stenosis. Thrombus in the
   left atrial appendage.
   CXR: worsening infilterates involving midzones of both lungs suggests
   superimposed
   multifocal pneumonia or unusual pattern of progression of heart
   failure. The
   remainder of the study including the lines and tubes are unchanged.
Sputum: GRAM STAIN (Final [**2114-11-3**]):
      >25 PMNs and <10 epithelial cells/100X field.
      NO MICROORGANISMS SEEN.
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   .
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.
   -          Start low dose Metoprolol IV for HR control to help forward
   flow.
   -          Lasix prn
   Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Need to have dialogue with
   surgery if she will be candidate for surgery in the future.
   - Will continue Heparin gtt
   - TEE today
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused
   - GI recs for endoscopy
   - Will transfuse as needed
   - Trend HCT
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   .
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   .
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - Check CDiff, start IV Flagyl
   .
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   .
   # Hypothyroidism:  Continue home synthroid.
   .
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   .
   FEN: Low salt, thickened liquids
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: Full Code.  Will need to be readdressed with family.
   DISPO: CCU for now
   .
   . IV access: Temporary central access (ICU) Location: Right Internal
   Jugular, Date inserted: [**2114-11-3**] Order date: [**11-3**] @ 0903
   16. Lidocaine Viscous 2% 20 ml PO ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 1139
   2. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   0903
   17. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ 0903
   3. Acetaminophen 650 mg PO ONCE Duration: 1 Doses Order date: [**11-3**] @
   2106
   18. MetRONIDAZOLE (FLagyl) 500 mg IV Q8H
   Start [**11-3**]  Order date: [**11-3**] @ 0914
   4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN  Order date: [**11-3**] @ 1542
   19. Meropenem 500 mg IV Q6H Duration: 48 Hours Order date: [**11-3**] @ 1846
   5. BuPROPion (Sustained Release) 150 mg PO QAM  Order date: [**11-2**] @
   2053
   20. Metoprolol Tartrate 5 mg IV ONCE Duration: 1 Doses Order date:
   [**11-3**] @ [**2032**]
   6. Bumetanide 1 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 2244
   21. Midazolam 1 mg IV PRN  Order date: [**11-3**] @ 1139
   7. Fentanyl Citrate 25-100 mcg IV PRN  Order date: [**11-3**] @ 1138
   22. Ondansetron 4 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0800
   8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH [**Hospital1 **]  Order date:
   [**11-2**] @ [**2015**]
   23. Paroxetine 30 mg PO DAILY  Order date: [**11-2**] @ 2053
   9. Furosemide 40 mg IV ONCE Duration: 1 Doses Order date: [**11-3**] @ 0903
   24. Pantoprazole 40 mg IV Q12H  Order date: [**11-3**] @ 1300
   10. Gabapentin 300 mg PO TID  Order date: [**11-2**] @ 2053
   25. Pneumococcal Vac Polyvalent 0.5 ml IM ASDIR  Order date: [**11-2**] @
   [**2010**]
   11. Heparin IV per Weight-Based Dosing Guidelines
   Order date: [**11-2**] @ [**2008**]
   26. Potassium Chloride 40 mEq / 100 ml SW IV ONCE Duration: 1 Doses
   Order date: [**11-3**] @ 1543
   12. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**11-2**] @ [**2010**]
   27. Simvastatin 40 mg PO DAILY  Order date: [**11-2**] @ 2053
   13. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-2**] @ [**2014**]
   28. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush
   Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and
   PRN.  Order date: [**11-3**] @ 0903
   14. Ipratropium Bromide Neb 1 NEB IH Q6H PRN  Order date: [**11-3**] @ 1542
   29. Vancomycin 1000 mg IV Q 12H
   ID Approval will be required for this order in 51 hours.  Order date:
   [**11-3**] @ 0445
   15. Levothyroxine Sodium 25 mcg PO DAILY  Order date: [**11-2**] @ [**2010**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, I summarize the patient's health progress in the ICU as follows:

The patient is a 66-year-old female who was admitted with a history of CVA with hemorrhagic evolution, AV and MV valves, and thrombosis. She was transferred from another hospital with a prosthetic mitral valve thrombus and gastrointestinal bleed. The patient has been experiencing acute congestive heart failure secondary to mitral valve thrombus and atrial fibrillation.

The patient's current vital signs are:

* Temperature: 101.6F (38.7C)
* Heart rate: 86 beats per minute (bpm)
* Blood pressure: 97/47 mmHg
* Respiratory rate: 24 inspirations per minute
* SpO2: 99%

The patient's physical examination reveals:

* Chest: diffuse rales in the posterior lung fields
* Abdomen: soft, with voluntary guarding and no rebound tenderness
* Extremities: no clubbing, cyanosis, or edema
* Neurological examination: CN II-XII intact, with exceptions noted (plantar flexion of left and right lower extremities, handgrip on right and left, absent left-sided startle reflex, left lid lag, and facial droop)

Laboratory results show:

* White blood cell count: 25.0 cells/L
* Hemoglobin: 25.9 g/dL
* Platelet count: 355 cells/L
* Creatinine: 1.0 mg/dL
* Troponin-T: 0.05 ng/mL
* Lactic acid: 2.7 mmol/L
* Albumin: 2.9 g/dL
* LDH: 462 IU/L
* Calcium: 8.1 mg/dL
* Magnesium: 2.1 mg/dL
* Phosphate: 1.8 mg/dL

The patient's medical complications include:

* Prosthetic mitral valve thrombus causing severe mitral stenosis
* Severe aortic stenosis
* Thrombus in the left atrial appendage
* Acute congestive heart failure
* Gastrointestinal bleed
* Atrial fibrillation
* Poorly rate-controlled
* Coronary artery disease (documented in OSH records)
* Pump failure (previous TTE showed EF of 50% with no thrombus)

Potential medical complications that can arise include:

* Further embolic events due to the thrombus
* Infection of the prosthetic mitral valve
* Progressive heart failure
* Worsening of the gastrointestinal bleed
* Development of pneumonia or other respiratory complications
* Increased risk of bleeding due to anticoagulation therapy
* Potential for digoxin toxicity due to elevated digoxin levels

The patient's plan of care includes:

* Start low-dose metoprolol IV for heart rate control
* Continue heparin gtt for further thrombus progression
* TEE today
* Start IV flagyl for suspected infected thrombus
* Continue vancomycin and meropenem for suspected sepsis
* Check CDiff and start IV flagyl if positive
* Continue prophylaxis for DVT and PE
* Full code status
* CCU for now

The patient's medications include:

* Metoprolol tartrate 5 mg IV
* Lasix 40 mg IV
* Furosemide 40 mg IV
* Midazolam 1 mg IV PRN
* Ondansetron 4 mg IV
* Fentanyl citrate 25-100 mcg IV PRN
* Albuterol 0.083% neb soln 1 neb IH Q6H PRN
* Simvastatin 40 mg PO daily
* Levothyroxine sodium 25 mcg PO daily
* Gabapentin 300 mg PO TID
* Potassium chloride 40 mEq/100 mL SW IV
* Sodium chloride 0.9% flush 10 mL IV PRN
* Vancomycin 1000 mg IV Q12H
* Ipratropium bromide neb 1 neb IH Q6H PRN
* Insulin SC (per insulin flowsheet)
* Fluticasone-salmeterol diskus 250/50 1 inh IH
* Pantoprazole 40 mg IV Q12H
* Pneumococcal vac polyvalent 0.5 mL IM ASDIR
* Influenza virus vaccine 0.5 mL IM ASDIR
* Heparin IV per weight-based dosing guidelines
* Simvastatin 40 mg PO daily
* Levothyroxine sodium 25 mcg PO daily
* Gabapentin 300 mg PO TID"
139476.0,203250,2114-11-05 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed, now made
   CMO
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family and they have elected to make the
   patient DNR/DNI and CMO.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   -          stop lab draws
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will cont BB
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - discontinue Vanco and Meropenem
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Cont BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI, CMO
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:  Oral meds
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed, now made
   CMO
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family and they have elected to make the
   patient DNR/DNI and CMO.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   -          stop lab draws
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will cont BB
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - discontinue Vanco and Meropenem
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Cont BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI, CMO
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:  Oral meds
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is a 66-year-old female who had a stroke with hemorrhagic evolution (CVA) and was transferred to the ICU with a prosthetic mitral valve and mitral valve thrombosis, as well as a gastrointestinal (GI) bleed. She has been experiencing atrial fibrillation and has a history of coronary artery disease (CAD). The patient has been treated with various medications, including heparin, warfarin, and metoprolol.

The patient's current condition is as follows:

* Vital signs: Temperature 38.2C (100.7F), heart rate 88 beats per minute, blood pressure 86/49 mmHg, respiratory rate 23 breaths per minute, and oxygen saturation 98%.
* Hemodynamic monitoring: Central venous pressure (CVP) 9 mmHg, cardiac index 2.2 L/min/m, and pulmonary artery pressure (PAP) 28/15 mmHg.
* Respiratory support: Continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) at 10 cmH2O and 5 cmH2O, respectively.
* Neurological status: The patient is awake and moves all four extremities with commands, but has significant weakness in the left arm and leg.
* Laboratory results: The patient has an elevated white blood cell count (WBC) of 25,000 cells/L, and her platelet count is 20,000 cells/L. Her lactate level is 1.3 mmol/L, and her troponin level is 0.05 ng/mL.

Potential medical complications that may arise include:

1. Pulmonary embolism (PE): Given the patient's history of thrombosis and atrial fibrillation, there is a risk of developing a PE.
2. Infectious complications: The patient's elevated WBC count and lactate level suggest the possibility of an infection, which could be related to the GI bleed or the prosthetic valve.
3. Cardiac complications: The patient's atrial fibrillation and mitral valve thrombosis may lead to cardiac complications such as heart failure or arrhythmias.
4. Gastrointestinal complications: The patient's GI bleed may continue to bleed or may develop complications such as perforation or abscesses.
5. Neurological complications: The patient's neurological deficits may worsen or new deficits may develop due to the stroke or other underlying conditions.
6. Bleeding complications: The patient's coagulopathy and thrombocytopenia may lead to bleeding complications such as epistaxis, hematuria, or melena.
7. Endocarditis: The patient's prosthetic valve and history of thrombosis may increase the risk of developing endocarditis.

Based on the patient's condition and potential complications, the following plan is recommended:

1. Continue heparin therapy to prevent further thrombosis and embolism.
2. Monitor the patient's cardiac status closely and adjust medications as necessary to prevent cardiac complications.
3. Manage the patient's GI bleed with continued transfusions and medications as necessary.
4. Monitor the patient's neurological status closely and adjust medications as necessary to prevent further neurological deficits.
5. Consider prophylactic antibiotics to prevent infectious complications.
6. Continue to monitor the patient's laboratory results, including WBC count, lactate level, and troponin level, to identify any potential complications early."
139476.0,203250,2114-11-05 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   24 Hour Events:
   Heparin d/c
ed.  Patient made DNR/DNI, family considering CMO if
   patient worsens.
   Allergies:
   Lasix (Oral) (Furosemide)
   Hives;
   Codeine
   Rash;
   Ceclor (Oral) (Cefaclor)
   Unknown;
   Keflex (Oral) (Cephalexin Monohydrate)
   Rash;
   Voltaren (Oral) (Diclofenac Sodium)
   Unknown;
   Penicillins
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2114-11-4**] 01:59 AM
   Vancomycin - [**2114-11-5**] 12:00 AM
   Meropenem - [**2114-11-5**] 02:00 AM
   I
   Other ICU medications:
   Morphine Sulfate - [**2114-11-4**] 04:29 PM
   Other medications:
   SSI
   Simvastatin 40mg
   Buproprion 150mg
   Paroxetene 30mg
   Gabapentin 300mg TID
   Fluticasone/Salmertol discus
   Levothyroxine 25mcg
   Vancomycin 1g q12hrs
   Pantoprazole 40mg q12hrs
   Meropenem IV q6hrs x 48hts
   Digoxin 0.125mg daily
   Bumetanide 1mg [**Hospital1 **]
   Lopressor 25mg TID
   Clonazepam 0.5mg TID
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2114-11-5**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.2
C (100.7
   Tcurrent: 36.9
C (98.5
   HR: 88 (80 - 109) bpm
   BP: 86/49(55) {79/36(48) - 106/63(72)} mmHg
   RR: 23 (23 - 33) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 83.9 kg (admission): 85.6 kg
    CVP: 9 (-5 - 222)mmHg
   Total In:
                                                                  2,702 mL
                                                                    436 mL
   PO:
                                                                    950 mL
                                                                     60 mL
   TF:
   IVF:
                                                                  1,452 mL
                                                                    376 mL
   Blood products:
   Total out:
                                                                  1,860 mL
                                                                    220 mL
   Urine:
                                                                  1,860 mL
                                                                    220 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    842 mL
                                                                    216 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 740 (740 - 740) mL
   PS : 10 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 70%
   PIP: 15 cmH2O
   SpO2: 98%
   ABG: ///24/
   Ve: 15.3 L/min
   Physical Examination
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: No JVD
   CARDIAC: RRR, with loud S2, crescendo-decrescendo murmur at LUSB
   LUNGS: Diffuse rales in posterior lung fields, obscured by BiPAP
   ABDOMEN: Soft, RLQ TTP.  Voluntary guarding.  No rebound.
   EXTREMITIES: No c/c/e. No femoral bruits.
   Neuro:  Moves all 4 with commands.  [**1-23**] handgrip on R, 0/5 on L.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   220 K/uL
   7.9 g/dL
   131 mg/dL
   1.2 mg/dL
   24 mEq/L
   3.8 mEq/L
   19 mg/dL
   107 mEq/L
   136 mEq/L
   23.3 %
   14.1 K/uL
        [image002.jpg]
                            [**2114-11-2**]  05:00 PM
                            [**2114-11-2**]  09:28 PM
                            [**2114-11-3**]  03:10 AM
                            [**2114-11-3**]  03:22 PM
                            [**2114-11-3**]  06:17 PM
                            [**2114-11-4**]  05:23 AM
                            [**2114-11-4**]  11:52 AM
                            [**2114-11-5**]  05:32 AM
   WBC
   20.8
   25.0
   21.3
   14.1
   Hct
   29.3
   25.9
   32
   26.7
   24.8
   23.3
   Plt
   [**Telephone/Fax (3) 6523**]20
   Cr
   1.0
   1.0
   1.2
   1.2
   TropT
   0.05
   TCO2
   24
   Glucose
   130
   155
   133
   131
   Other labs: PT / PTT / INR:14.9/41.1/1.3, CK / CKMB /
   Troponin-T:58//0.05, ALT / AST:33/62, Alk Phos / T Bili:99/0.4, Amylase
   / Lipase:49/53, Differential-Neuts:86.5 %, Lymph:7.7 %, Mono:4.6 %,
   Eos:0.9 %, Lactic Acid:2.7 mmol/L, Albumin:2.9 g/dL, LDH:462 IU/L,
   Ca++:8.0 mg/dL, Mg++:2.0 mg/dL, PO4:1.3 mg/dL
   Assessment and Plan
   66 y/o F s/p CVA with hemorrhagic evolution ([**9-26**]) with AV and MV
   valves transferred from OSH with MV thrombosis and GI bleed
   # Prosthetic Mitral Valve Thrombus:  Echocardiogram consistent with
   thrombus on prosthetic MV valve and fluroscopy shows one leaflet that
   is fixed.  Patient has TTE during admission at [**Hospital1 1817**] three weeks ago
   that was negative for valvular thrombus.  TTE shows gradient pressures
   of Mitral 28/(mean)18 and Aortic 45/(mean)23.  Given the patient had
   recently had a hemorrhagic stroke and recent GI bleed, the management
   will be difficult.  Patient had resumed coumadin on transfer to
   rehabilitation to prevent further clots.  Patient would likely be a
   poor surgical candidate.  This issue represents an end-stage disease
   and this is understood by family.
   - Will continue Heparin gtt
   - Palliative care consult
   - Goal to get home with family, respiratory support and pain control
   # Acute Congestive Heart Failure:  Secondary to Mitral valve thrombus
   and atrial fibrillation.  Patient has high gradient between LA and LV,
   also not filling well secondary to functional stenosis secondary to
   thrombus.   Good response to low-dose IV metoprolol.
   - PO metoprolol 25 mg TID.
   - Bumex 1 mg [**Hospital1 **], which is
 home dose with goal of even
   # GI bleed:  Unclear source, likely lower GI.  HCT dropped from 29 to
   25 this AM and was subsequently transfused.  Hct responded
   appropriately but then came back down.
   - GI recs for endoscopy
   - Transfusion for symptomatic anemia
   # Atrial Fibrillation:  Poorly rate controlled.  Dig level 1.1, likely
   toxic level in this patient in light of her EKG changes.
   - Will start BB
   - Heparin gtt for further thrombus progression
   .
   # CORONARIES:  h/o CAD documented in OSH records, however patient had
   cath in [**2109**] that showed normal coronaries. Pt had STD on EKG possibly
   in setting of GI Bleed/demand or related to digoxin toxicity.
   # PUMP:  Previous TTE at [**Hospital1 1817**] 3 wks ago showed EF of 50% with no
   thrombus, with presence of dilated left atrium.
   - TEE today
   # RLL Pneumonia:  Possible cause of her elevated WBC of 25 this AM.
   Lactate 1.3.  WBC at OSH was elevated.  Afebrile.  Not apparent that
   BCx obtained at OSH.  In context of thrombus, differential includes
   infected thrombus for leukocytosis.  C. diff negatibe
   - BCx and UCx pending
   - Continue Vanco and Meropenem
   - D/C flagyl
   # HTN:  BP 108/43.  SBPs on admission in 80s.
   - Start BB.
   # Hypothyroidism:  Continue home synthroid.
   # s/p hemorrhagic stroke:  Patient with neurological deficits on exam.
   Patient at risk for further embolic event with thrombus.
   FEN: Low salt, thickened liquids, advance to full
   ACCESS: 18 gauge PIV and R IJ
   PROPHYLAXIS:
   -DVT ppx with Hep gtt, IV PPI
   CODE: DNR/DNI
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2114-11-3**] 06:02 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 66-year-old female who has suffered a hemorrhagic stroke with a prosthetic mitral valve and has developed a prosthetic mitral valve thrombus. She has also had a gastrointestinal bleed and is experiencing atrial fibrillation.

The patient's current medical conditions include:

* Prosthetic mitral valve thrombus: The patient has a prosthetic mitral valve thrombus that is causing a high gradient between the left atrium and left ventricle, leading to poor filling of the left ventricle.
* Acute congestive heart failure: The patient has developed acute congestive heart failure secondary to the mitral valve thrombus and atrial fibrillation.
* Gastrointestinal bleed: The patient has had a gastrointestinal bleed, likely in the lower gastrointestinal tract, which has led to a drop in her hemoglobin level.
* Atrial fibrillation: The patient has poorly rate-controlled atrial fibrillation, which is likely contributing to her congestive heart failure.
* Hypothyroidism: The patient has hypothyroidism, which is being managed with levothyroxine.
* Hemorrhagic stroke: The patient has a history of hemorrhagic stroke, which has left her with neurological deficits.

The patient's current medications include:

* Heparin: The patient is receiving heparin to prevent further thrombus formation and to treat her atrial fibrillation.
* Metoprolol: The patient is receiving metoprolol to control her atrial fibrillation and to reduce her blood pressure.
* Digoxin: The patient is receiving digoxin to control her atrial fibrillation, but the level of digoxin in her blood is likely toxic.
* Furosemide: The patient is receiving furosemide to manage her congestive heart failure.
* Pantoprazole: The patient is receiving pantoprazole to manage her gastrointestinal bleed.

The patient's laboratory results include:

* Complete blood count: The patient's complete blood count shows a white blood cell count of 25,000/mm3, which is elevated.
* Blood chemistry: The patient's blood chemistry shows a creatinine level of 1.2 mg/dL, which is elevated.
* Electrolytes: The patient's electrolyte levels are normal.
* Troponin-T: The patient's troponin-T level is 0.05 ng/mL, which is elevated.

The patient's imaging studies include:

* Echocardiogram: The patient's echocardiogram shows a prosthetic mitral valve thrombus and a high gradient between the left atrium and left ventricle.
* Fluoroscopy: The patient's fluoroscopy shows a fixed leaflet on the prosthetic mitral valve.

The patient's plan of care includes:

* Continuing heparin to prevent further thrombus formation and to treat her atrial fibrillation.
* Continuing metoprolol to control her atrial fibrillation and to reduce her blood pressure.
* Continuing furosemide to manage her congestive heart failure.
* Continuing pantoprazole to manage her gastrointestinal bleed.
* Considering a palliative care consult to discuss the patient's goals of care and to manage her symptoms.
* Considering a gastroenterology consult to evaluate the patient's gastrointestinal bleed and to consider endoscopy.
* Considering a cardiology consult to evaluate the patient's prosthetic mitral valve thrombus and to consider further management options.

The potential medical complications that could arise in this patient include:

* Further thrombus formation and embolization
* Worsening of congestive heart failure
* Development of atrial fibrillation
* Gastrointestinal bleeding
* Infection of the prosthetic mitral valve thrombus
* Further neurological deficits from the hemorrhagic stroke."
